FrancophonIA/ELRC3.0 huggingface dataset:
English: The proportion of patients achieving HbA1c < 7 % at week 24 for add-on therapy with saxagliptin to dapagliflozin plus metformin trial was higher in the saxagliptin plus dapagliflozin plus metformin group 35.3 % (95 % CI [28.2, 42.2]) compared to the placebo plus dapagliflozin plus metformin group 23.1 % (95 % CI [16.9, 29.3]).
Slovenian: Delež bolnikov, ki so dosegli HbA1c < 7,0 % do 24. tedna preskušanja dodatnega zdravljenja s saksagliptinom, dodanega kombinaciji dapagliflozina in metformina, je bil večji v skupini s kombinacijo saksagliptina, dapagliflozina in metformina (35,3 %; 95 % IZ: 28,2, 42,2) kot v skupini s kombinacijo placeba, dapagliflozina in metformina (23,1 %; 95 % IZ: 16,9, 29,3).
English: Post-marketing reports of rash have been described in the DPP-4 inhibitor class.
Slovenian: V skupini zaviralcev DPP-4 je bil v obdobju trženja zdravila opisan izpuščaj.
English: The saxagliptin and dapagliflozin group achieved significantly greater reductions in HbA1c versus either the saxagliptin group or dapagliflozin group at 24 weeks (see table 2).
Slovenian: Po 24 tednih je skupina, ki je prejemala saksagliptin in dapagliflozin, dosegla značilno večje znižanje HbA1c kot skupina zgolj s saksagliptinom ali skupina zgolj z dapagliflozinom (glejte preglednico 2).
English: Preferred terms reported in dapagliflozin clinical trials included in order of frequency: rash, rash generalised, rash pruritic, rash macular, rash maculo-papular, rash pustular, rash vesicular, and rash erythematous.
Slovenian: Prednostni izrazi, poročani v kliničnih preskušanjih dapagliflozina, vključeni v zaporedju po pogostnosti: izpuščaj, generaliziran izpuščaj, srbeč izpuščaj, makularen izpuščaj, makulo-papularen izpuščaj, pustularen izpuščaj, vezikularen izpuščaj in eritematozen izpuščaj.
English: Bioequivalence has been confirmed between the Qtern 5 mg/10 mg tablet and the individual saxagliptin 5 mg and dapagliflozin 10 mg tablets after single dose administration in the fasted state in healthy subjects.
Slovenian: Po uporabi enkratnega odmerka na tešče pri zdravih preiskovancih je bila potrjena bioekvivalentnost tablet Qtern 5 mg/10 mg in posamezno uporabljenih tablet 5 mg saksagliptina in tablet 10 mg dapagliflozina.
English: Glycaemic control should be assessed when it is used concomitantly with a potent CYP3A4/5 inducer (see section 4.5).
Slovenian: Če je zdravilo uporabljeno sočasno z močnim induktorjem CYP3A4/5, je treba oceniti urejenost glikemije (glejte poglavje 4.5).
English: Saxagliptin/dapagliflozin combination: Cardiovascular (CV) events that were adjudicated and confirmed as CV events were reported in a total of 1.0 % of subjects in the saxagliptin plus dapagliflozin plus metformin group, 0.6 % in the saxagliptin plus metformin group, and 0.9 % in the dapagliflozin plus metformin group.
Slovenian: Kombinacija saksagliptina/dapagliflozina: O tistih srčno-žilnih neželenih dogodkih, ki so bili ovrednoteni in potrjeni kot srčno-žilni dogodkih, so poročali pri skupaj 1,0 % prejemnikov kombinacije saksagliptina, dapagliflozina in metformina, pri 0,6 % prejemnikov kombinacije saksagliptina in metformina ter pri 0,9 % prejemnikov kombinacije dapagliflozina in metformina.
English: Patients should be advised to seek medical attention if they experience a combination of symptoms of pain, tenderness, erythema, or swelling in the genital or perineal area, with fever or malaise.
Slovenian: Bolnikom s simptomi, ki vključujejo bolečino, občutljivost, eritem ali otekanje v genitalnem predelu ali predelu presredka, skupaj s povišano telesno temperaturo in slabim počutjem, je treba svetovati, naj poiščejo zdravniško pomoč.
English: Saxagliptin 5 mg added to dapagliflozin 10 mg + metformin
Slovenian: 5 mg saksagliptina, dodanega kombinaciji 10 mg dapagliflozina in metformina
English: Qtern 5 mg/10 mg film-coated tablets saxagliptin/dapagliflozin
Slovenian: Qtern 5 mg/10 mg filmsko obložene tablete saksagliptin/dapagliflozin
English: Increases in the amount of glucose excreted in the urine were observed in healthy subjects and in subjects with type 2 diabetes mellitus following the administration of dapagliflozin.
Slovenian: Pri zdravih osebah in bolnikih s sladkorno boleznijo tipa 2 so po uporabi dapagliflozina opažali povečanje izločanja glukoze v urinu.
English: One patient in the saxagliptin plus dapagliflozin plus metformin group experienced an SAE of pyelonephritis and discontinued treatment.
Slovenian: Pri enem prejemniku kombinacije saksagliptina, dapagliflozina in metformina se je kot resen neželeni učinek pojavil pielonefritis in bolnik je prekinil zdravljenje.
English: Dapagliflozin 10 mg add to saxagliptin 5 mg + metformin
Slovenian: 10 mg dapagliflozina, dodanega kombinaciji 5 mg saksagliptina in metformina
English: Rash was reported during the postmarketing use of saxagliptin and dapagliflozin.
Slovenian: O izpuščaju so poročali med uporabo saksagliptina in dapagliflozina v obdobju trženja.
English: Symptoms can include, but are not limited to, increasing shortness of breath, rapid increase in weight and swelling of the feet (pedal oedema).
Slovenian: Med simptomi so lahko stopnjujoča se zadihanost, hiter porast telesne mase in oteklost stopal, lahko pa se pojavijo še drugi simptomi.
English: Urinary tract infection vulvovaginitis, balanitis and related genital infection gastroenteritis
Slovenian: Infekcijske in parazitske bolezni okužba zgornjih dihal okužba sečil vulvovaginitis, balanitis in sorodne okužbe spolovil gastroenteritis glivična okužba nekrotizirajoči fasciitis presredka (Fournierjeva gangrena)
English: No dose- and time-dependence was observed in the clearance of saxagliptin and its major metabolite over 14 days of once-daily dosing with saxagliptin at doses ranging from 2.5 mg to 400 mg.
Slovenian: Med 14-dnevno uporabo saksagliptina v odmerkih od 2,5 mg od 400 mg enkrat na dan niso ugotovili nobene odvisnosti očistka saksagliptina ali njegovega glavnega presnovka od odmerka ali od časa.
English: (sinusitis) - inflamed nose or throat (nasopharyngitis) (signs of this may include a cold or a sore throat) - stomach ache and indigestion (dyspepsia) - nausea - diarrhoea - inflamed stomach or gut usually caused by an infection (gastroenteritis) - headache, muscle pain (myalgia) - vomiting, inflammation of the stomach (gastritis) - changes in laboratory tests (for example creatinine renal clearance decreased or haematocrit increased).
Slovenian: nenavaden izcedek ali neprijeten vonj) - bolečine v hrbtu - odvajanje več vode (urina) kot po navadi ali potreba po pogostejšem odvajanju vode - spremenjena količina holesterola ali maščob v krvi (to pokaže preiskava krvi) - povečanje števila rdečih krvnih celic v krvi (to pokažejo laboratorijske preiskave) - zmanjšanje ledvičnega očistka kreatinina (to se pokaže v preiskavah) - omotica - utrujenost - bolečine v trebuhu - hude bolečine v sklepih (artralgija) - okužba v zgornjem delu prsnega koša ali v pljučih - okužba obnosnih votlin z bolečinami in občutkom polnosti za lici in očmi (sinuzitis) - vnetje v nosu ali žrelu (nazofaringitis) (med znaki so lahko nahod ali vneto žrelo) - bolečine v želodcu in težave z želodcem (dispepsija) - slabost (navzea) - driska - vnetje želodca ali črevesa, po navadi zaradi okužbe (gastroenteritis) - glavobol, bolečine v mišicah (mialgija) - bruhanje, vnetje želodca (gastritis) - spremembe izvidov laboratorijskih preiskav (npr. zmanjšanje ledvičnega očistka kreatinina ali porast hematokrita) - izpuščaj
English: Talk to your doctor immediately if you develop a combination of symptoms of pain, tenderness, redness, or swelling of the genitals or the area between the genitals and the anus with fever or feeling generally unwell.
Slovenian: Če se pri vas pojavi kombinacija simptomov, ki vključujejo bolečino, občutljivost, rdečico ali otekanje spolovil ali predela med spolovili in zadnjikom, skupaj s povišano telesno temperaturo ali splošnim slabim počutjem, se takoj posvetujte z zdravnikom.
English: If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Slovenian: Če imate dodatna vprašanja, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: Qtern contains lactose
Slovenian: Zdravilo Qtern vsebuje laktozo
English: How to store Qtern
Slovenian: Shranjevanje zdravila Qtern
English: No appreciable accumulation of either saxagliptin or its major metabolite was observed with repeated once-daily dosing at any dose level.
Slovenian: Med večkratnim odmerjanjem enkrat na dan ni pri nobenem odmerku prišlo do upoštevanja vrednega kopičenja saksagliptina ali njegovega glavnega presnovka.
English: Glycaemic control should be carefully assessed when saxagliptin is used concomitantly with a potent CYP3A4/5 inducer.
Slovenian: Če je saksagliptin uporabljen skupaj s kakšnim močnim induktorjem CYP3A4/5, je treba urejenost glikemije skrbno ocenjevati.
English: Dyslipidaemia
Slovenian: Diuretiki
English: HbA1c irrespective of baseline HbA1c compared with saxagliptin or dapagliflozin alone added to metformin.
Slovenian: Kombinacija saksagliptina in dapagliflozina, dodana metforminu, je HbA1c dosledno znižala bolj (ne glede na izhodiščni HbA1c) kot saksagliptin ali dapagliflozin, dodana metforminu vsak zase.
English: Adjusted mean
Slovenian: Prilagojeno povprečje
English: België/Belgique/Belgien AstraZeneca S.A./N.V.
Slovenian: België/Belgique/Belgien
English: CALENDAR BLISTERS
Slovenian: Urejenost glikemije
English: Urosepsis and pyelonephritis
Slovenian: Urosepsa in pielonefritis
English: Remember to take other medicine(s) as your doctor has told you.
Slovenian: Pri jemanju drugega zdravila/drugih zdravil upoštevajte zdravnikova navodila.
English: Placebo + dapagliflozin 10 mg + metformin
Slovenian: Placebo + 10 mg dapagliflozina + metformin (N = 162)
English: Film-coating
Slovenian: KOLEDARSKI PRETISNI OMOTI
English: Haematocrit increase was observed with dapagliflozin treatment, (see section 4.8); therefore, caution in patients with already elevated haematocrit is warranted.
Slovenian: Med zdravljenjem z dapagliflozinom so opažali zvišanje hematokrita (glejte poglavje 4.8).
English: Angioedema
Slovenian: Hipoglikemija
English: The majority of the genital infection adverse events were reported in females (84 % of subjects with a genital infection), were mild or moderate in intensity, of single occurrence, and most patients continued on therapy.
Slovenian: O večini okužb spolovil so poročali pri ženskah (84 % preiskovancev z okužbo spolovil).
English: C, urticaria
Slovenian: C, urtikarija angioedem
English: Experience in NYHA class I-II is limited in dapagliflozin.
Slovenian: • Učinkovini sta saksagliptin in dapagliflozin.
English: Talk to your doctor if you would like to or are breast-feeding before taking this medicine.
Slovenian: Če dojite ali želite dojiti, se pred jemanjem tega zdravila posvetujte z zdravnikom.
English: A total of 534 adult patients with type 2 diabetes mellitus and inadequate glycaemic control on metformin alone (HbA1c ≥ 8 % and ≤ 12 %), participated in this 24-week randomised, double-blind, active comparator-controlled superiority trial to compare the combination of saxagliptin and dapagliflozin added concurrently to metformin, versus saxagliptin (DPP-4 inhibitor) or dapagliflozin (SGLT2 inhibitor) added to metformin.
Slovenian: To 24-tedensko randomizirano, dvojno slepo, z aktivno učinkovino kontrolirano preskušanje je zajelo skupaj 534 odraslih bolnikov s sladkorno boleznijo tipa 2, ki glikemije niso imeli ustrezno urejene s samim metforminom (HbA1c ≥ 8 % in ≤ 12 %).
English: F, blood urea increased, weight decreased
Slovenian: zvišanje hematokrita zvišanje kreatinina v krvi zvišanje sečnine v krvi, zmanjšanje telesne mase
English: Other side effects when taking Qtern alone or in combination with metformin: Common - genital infection (thrush) of your penis or vagina (signs may include irritation, itching, unusual discharge or odour) - back pain - passing more water (urine) than usual or needing to pass water more often - changes in the amount of cholesterol or fats in your blood (shown in tests) - increases in the amount of red blood cells in your blood (shown in tests) - decreases in creatinine renal clearance (shown in tests)
Slovenian: Drugi neželeni učinki med jemanjem zdravila Qtern samega ali v kombinaciji z metforminom: Pogosti - okužba spolovil (glivice) na spolnem udu ali v nožnici (med znaki so lahko draženje, srbenje,
English: Description of selected adverse reactions Hypoglycaemia
Slovenian: Uporaba z zdravili, ki povzročajo hipoglikemijo
English: Dermatitis
Slovenian: dislipidemija
English: Titanium dioxide (E171) Talc (E553b)
Slovenian: Filmska obloga polivinilalkohol (E1203) makrogol 3350 titanov dioksid (E171) smukec (E553b) rumeni železov oksid (E172) rdeči železov oksid (E172)
English: Volume depletion F,
Slovenian: 4 zmanjšanje volumna
English: This overview was last updated in November 2018.
Slovenian: Pregled je bil nazadnje posodobljen novembra 2018.
English: This will help to protect them against the disease.
Slovenian: Ta mu bodo pomagala pri obrambi pred boleznijo.
English: Further information on Syvazul BTV can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/syvazul-btv.
Slovenian: Nadaljnje informacije o cepivu Syvazul BTV so na voljo na spletni strani agencije: ema.europa.eu/medicines/veterinary/EPAR/syvazul-btv.
English: The European Medicines Agency decided that Syvazul BTV's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi cepiva Syvazul BTV večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: The second injection is given 3 weeks after the first.
Slovenian: Drugi odmerek se injicira tri tedne po injiciranju prvega.
English: The main measure of effectiveness was the presence of virus in the blood and the studies have shown that the vaccine is effective in producing protective antibodies in sheep and cattle.
Slovenian: Glavno merilo učinkovitosti je bila prisotnost virusa v krvi, študije pa so pokazale, da je cepivo učinkovito pri tvorjenju zaščitnih protiteles pri ovcah in govedu.
English: People who are hypersensitive (allergic) to aluminium hydroxide, thiomersal or saponins should avoid contact with Syvazul BTV.
Slovenian: Ljudje, ki so preobčutljivi za (alergični na) aluminijev hidroksid, tiomersal ali saponine, se morajo izogibati stiku s cepivom Syvazul BTV.
English: Syvazul BTV received a marketing authorisation valid throughout the EU on 9 January 2019.
Slovenian: Cepivo Syvazul BTV je pridobilo dovoljenje za promet, veljavno po vsej EU, 09/01/2019.
English: The vaccine contains inactivated (killed) bluetongue viruses.
Slovenian: Cepivo vsebuje inaktivirane (uničene) viruse modrikastega jezika.
English: The most common side effects with Syvazul BTV (which may affect more than 1 in 10 animals) are local injection site reactions, erythema (reddening of the skin) with mild to moderate swelling 1 to 6 days after vaccination, a painless nodule (up to 3.8 cm diameter in sheep and 7 cm diameter in cattle) 2 to 6 days after vaccination and a short-lived increase in body temperature of no more than 2.3˚C in the 48 hours after vaccination.
Slovenian: Najpogostejši neželeni učinki zdravila Syvazul BTV (ki lahko prizadenejo več kot 1 žival od 10) so lokalne reakcije na mestu injiciranja, eritem (pordelost kože) z blago do zmerno oteklino, ki traja od enega do šest dni po cepljenju, neboleč vozlič (s premerom do 3,8 cm pri ovcah in 7 cm pri govedu), ki se pojavi od dva do šest dni po cepljenju in kratkotrajno povišanje telesne temperature za največ 2,3˚C v 48 urah po cepljenju.
English: The vaccine also contains ‘adjuvants' (aluminium hydroxide and saponin) that enhance the response of the immune system.
Slovenian: Vsebuje tudi „adjuvansa“ (aluminijev hidroksid in saponin) za povečanje imunskega odziva.
English: The vaccine is available as an injection and can only be obtained with a prescription.
Slovenian: Cepivo je na voljo v obliki injekcije, njegovo predpisovanje in izdaja pa je le na recept.
English: In the future, if the animals are exposed to the bluetongue virus, their immune system will be able to produce antibodies more quickly.
Slovenian: Ob ponovni izpostavitvi virusu modrikastega jezika v prihodnosti bo imunski sistem lahko hitreje tvoril protitelesa.
English: Other information about Syvazul BTV
Slovenian: Druge informacije o zdravilu Syvazul BTV
English: Syvazul BTV is a vaccine.
Slovenian: Zdravilo Syvazul BTV je cepivo.
English: The withdrawal period for meat and milk from sheep and cattle treated with Syvazul BRV is ‘zero' days, which means that there is no mandatory waiting time.
Slovenian: Karenca za meso in mleko ovac in goveda, cepljenih s cepivom Syvazul BTV, je „nič“ dni, kar pomeni, da ni obvezne čakalne dobe.
English: The variety (serotype) of the virus in the vaccine is selected depending on which serotypes are circulating and causing disease at the time of manufacture, so it may contain serotype 1, 4 or 8 or a combination of any two of these.
Slovenian: Vrsta (serotip) virusa v cepivu je izbrana glede na to, kateri serotipi krožijo in povzročajo obolenje v času proizvodnje cepiva, zato lahko vsebuje serotip 1, 4 ali 8 oziroma kombinacijo dveh serotipov.
English: For more information about using Syvazul BTV, see the package leaflet or contact your veterinarian or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Syvazul BTV glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
English: For the full list of side effects and restrictions of Syvazul BTV, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi cepiva Syvazul BTV glejte navodilo za uporabo.
English: An overview of Syvazul BTV and why it is authorised in the EU
Slovenian: Pregled zdravila Syvazul BTV in zakaj je odobreno v EU
English: The vaccine is given as two injections into a muscle to calves from 2 months of age if the calves have no immunity to bluetongue virus or from 3 months of age in calves born to mothers already immune to the disease.
Slovenian: Cepivo se v dveh odmerkih injicira v mišico teličkom v starosti od dveh mesecev dalje, če niso imuni proti virusu modrikastega jezika, ali v starosti od treh mesecev dalje, če so se skotili kravam, ki so proti tej bolezni že imune.
English: When it is given to sheep and cattle, the animals' immune systems recognise the viruses as ‘foreign' and make antibodies against them.
Slovenian: Ko ovce in govedo prejmejo cepivo, njihov imunski sistem prepozna viruse kot tujke in proti njim razvije protitelesa.
English: Syvazul BTV contains bluetongue viruses that have been inactivated so that they cannot cause the disease.
Slovenian: Cepivo Syvazul BTV vsebuje viruse modrikastega jezika, ki so inaktivirani in ne morejo povzročiti bolezni.
English: Why is Syvazul BTV authorised in the EU?
Slovenian: Zakaj je zdravilo Syvazul BTV odobreno v EU?
English: Syvazul BTV is a vaccine used in sheep and cattle to protect them against bluetongue disease, an infection caused by the bluetongue virus which is transmitted by midges.
Slovenian: Zdravilo Syvazul BTV je cepivo, ki se uporablja pri ovcah in govedu za zaščito pred boleznijo modrikastega jezika, tj. okužbo, ki jo prenašajo trzače, povzroča pa jo virus modrikastega jezika.
English: Safety information has been included in the summary of product characteristics and the package leaflet for Syvazul BTV, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
Slovenian: V povzetek glavnih značilnosti cepiva Syvazul BTV in navodilo za njegovo uporabo so bile vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in lastniki ali skrbniki živali.
English: Laboratory studies were conducted in which sheep and cattle vaccinated with Syvazul BTV were exposed to BTV serotype 1, 4 or 8.
Slovenian: Izvedene so bile laboratorijske študije, v katerih so bili ovce in govedo, cepljeni s cepivom Syvazul BTV, izpostavljeni serotipom 1, 4 ali 8 virusa bolezni modrikastega jezika.
English: No field studies were provided with BTV-4 in sheep or cattle, however, the laboratory studies were considered sufficient to show effectiveness of the BTV-4 vaccine.
Slovenian: Pri ovcah in govedu ni bilo opravljenih terenskih študij s serotipom 4 virusa modrikastega jezika, vendar so bile laboratorijske študije ocenjene kot zadostne za prikaz učinkovitosti cepiva za serotip 4.
English: What benefits of Syvazul BTV have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Syvazul BTV izkazalo v študijah?
English: What is Syvazul BTV and what is it used for?
Slovenian: Kaj je zdravilo Syvazul BTV in za kaj se uporablja?
English: What are the risks associated with Syvazul BTV?
Slovenian: Kakšna tveganja so povezana z zdravilom Syvazul BTV?
English: Revaccination is required after 1 year.
Slovenian: Po enem letu je treba cepljenje ponoviti.
English: Effectiveness was measured by comparing antibody levels to the virus at days 35 and 63 after vaccination with levels from laboratory studies.
Slovenian: Učinkovitost so merili s primerjavo ravni protiteles proti virusu na 35. in 63. dan po cepljenju z ravnmi iz laboratorijskih študij.
English: Effectiveness was measured by comparing antibody levels at 21 and 42 days after completing the initial vaccination course with levels from laboratory studies.
Slovenian: Učinkovitost so merili s primerjavo ravni protiteles na 21. in 42. dan po zaključku začetnega sklopa cepljenj z ravnmi iz laboratorijskih študij.
English: Syvazul BTV contains bluetongue virus of one or two types selected from serotypes 1, 4 and 8.
Slovenian: Cepivo Syvazul BTV vsebuje eno ali dve vrsti izbranih serotipov virusa bolezni modrikastega jezika, in sicer 1, 4 in 8.
English: The data showed that antibody levels at day 42 after vaccination for each group remained at levels similar to day 21 after vaccination and above levels from the laboratory studies.
Slovenian: Podatki so pokazali, da so ravni protiteles na 42. dan po cepljenju za vse skupine ostale podobne ravnem, doseženim na 21. dan po cepljenju, in nad ravnmi iz laboratorijskih študij.
English: The data showed that antibody levels at day 63 after vaccination for each group remained at levels similar to day 35 after vaccination and above levels from the laboratory studies.
Slovenian: Podatki so pokazali, da so ravni protiteles na 63. dan po cepljenju za vse skupine ostale podobne ravnem, doseženim na 35. dan po cepljenju, in nad ravnmi iz laboratorijskih študij.
English: Laboratory studies showed that in sheep the vaccine starts to be effective 39 days after vaccination and protection lasts for 1 year.
Slovenian: Laboratorijske študije so pokazale, da cepivo pri ovcah začne učinkovati 39 dni po cepljenju, zaščita pa traja eno leto.
English: Revaccination with one injection is required after 1 year.
Slovenian: Po enem letu je treba cepljenje ponoviti z enim odmerkom.
English: How is Syvazul BTV used?
Slovenian: Kako se zdravilo Syvazul BTV uporablja?
English: The vaccine starts to be effective 21 days after completion of the initial vaccination course and protection lasts one year.
Slovenian: Cepivo začne učinkovati 21 dni po zaključku začetnega sklopa cepljenja, zaščita pa traja eno leto.
English: In a field study, 3 groups of 35 lambs from 3 months of age (with no antibodies to bluetongue virus) received vaccination with vaccines containing BTV-1, BTV-8 and BTV 1+8.
Slovenian: V terenski študiji so tri skupine po 35 jagnjet v starosti od treh mesecev dalje (brez protiteles proti virusu modrikastega jezika) bile cepljene s cepivi, ki so vsebovala serotip 1 ali 8 oziroma kombinacijo serotipov 1 in 8 virusa modrikastega jezika.
English: Laboratory studies showed that in cattle the vaccine starts to be effective 21 days after completion of the initial vaccination course and protection lasts one year.
Slovenian: Laboratorijske študije so pokazale, da cepivo pri govedu začne učinkovati 21 dni po zaključku začetnega sklopa cepljenja, zaščita pa traja eno leto.
English: How does Syvazul BTV work?
Slovenian: Kako zdravilo Syvazul BTV deluje?